Lixia Xu Selected Research

Proteins (Proteins, Gene)

1/2024	Telitacicept Treatment Refractory Lupus Nephritis: A Case Report.
11/2023	Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
1/2023	TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
6/2022	YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
1/2022	Orally Administered Brain Protein Combined With Probiotics Increases Treg Differentiation to Reduce Secondary Inflammatory Damage Following Craniocerebral Trauma.
1/2021	CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells.
1/2020	AcMNPV PKIP is required for hyperexpression of very late genes and involved in the hyperphosphorylation of the viral basic protein P6.9.
1/2019	AcMNPV PKIP is associated with nucleocapsid of budded virions and involved in nucleocapsid assembly.
10/2018	Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
1/2018	HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lixia Xu Research Topics

Disease

49	Neoplasms (Cancer) 03/2024 - 03/2011
19	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 09/2014
14	Glioma (Gliomas) 02/2024 - 06/2016
10	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2014
7	Infections 03/2024 - 01/2019
7	Stomach Neoplasms (Stomach Cancer) 01/2018 - 03/2011
6	Carcinogenesis 02/2024 - 07/2020
5	Cholangiocarcinoma 03/2024 - 03/2016
4	Brain Injuries (Brain Injury) 04/2024 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 01/2020
4	Glomerulonephritis 01/2016 - 11/2014
4	Proteinuria 01/2016 - 01/2009
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2016
3	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2020 - 11/2014
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 10/2016
3	Inflammation (Inflammations) 11/2019 - 04/2011
2	Liver Neoplasms (Liver Cancer) 03/2024 - 09/2021
2	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2013
2	Lupus Nephritis 01/2024 - 11/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2021
2	Dyslipidemias (Dyslipidemia) 07/2023 - 04/2019
2	Non-alcoholic Fatty Liver Disease 01/2023 - 10/2018
2	Necrosis 06/2022 - 07/2012
2	Ischemia 06/2022 - 01/2016
2	Brain Edema (Cerebral Edema) 01/2022 - 11/2019
2	Craniocerebral Trauma (Head Injury) 01/2022 - 01/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2019
2	Stroke (Strokes) 09/2020 - 11/2017
2	Lymphoma (Lymphomas) 04/2020 - 01/2020
2	Cerebral Hemorrhage 01/2020 - 11/2017
2	Acute Kidney Injury (Acute Renal Failure) 02/2018 - 01/2010
2	Pancreatitis 01/2018 - 01/2014
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2014 - 01/2013
2	IGA Glomerulonephritis (IGA Nephropathy) 11/2014 - 01/2014
1	Bites and Stings (Sting) 04/2024
1	Clonorchiasis 03/2024
1	Fibrosis (Cirrhosis) 01/2024

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2009
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2013
10	Messenger RNA (mRNA)IBA 01/2024 - 01/2009
7	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2020
5	CytokinesIBA 01/2024 - 04/2011
4	Long Noncoding RNAIBA 02/2024 - 03/2021
4	Immune Checkpoint InhibitorsIBA 09/2023 - 01/2020
4	EnzymesIBA 07/2020 - 07/2012
4	apatinibIBA 11/2019 - 03/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017 - 07/2012
3	InterferonsIBA 04/2024 - 10/2018
3	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2013
3	N-methyladenosineIBA 01/2024 - 01/2021
3	Small Interfering RNA (siRNA)IBA 01/2024 - 06/2016
3	Temozolomide (Temodar)FDA LinkGeneric 11/2023 - 06/2016
3	Transfer RNA (tRNA)IBA 06/2023 - 01/2021
3	LipidsIBA 01/2022 - 04/2019
3	Therapeutic UsesIBA 01/2022 - 11/2019
3	entecavir FDA Link 11/2020 - 01/2016
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2017 - 03/2016
3	Tacrolimus (Prograf)FDA LinkGeneric 10/2016 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2024 - 02/2024
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 02/2024 - 01/2024
2	Phosphotransferases (Kinase)IBA 02/2024 - 01/2018
2	lenvatinibIBA 10/2023 - 01/2023
2	AntigensIBA 01/2023 - 01/2019
2	AlbuminsIBA 09/2021 - 11/2017
2	HydrogelsIBA 05/2021 - 05/2021
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2016
2	protein kinase inhibitor peptideIBA 01/2020 - 01/2019
2	InterleukinsIBA 10/2018 - 06/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2018 - 01/2017
2	CateninsIBA 01/2018 - 09/2014
2	Caspase 9IBA 01/2018 - 07/2012
2	Caspase 3 (Caspase-3)IBA 01/2018 - 07/2012
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2018 - 01/2013
2	Neutralizing AntibodiesIBA 01/2018 - 02/2017
2	CreatinineIBA 01/2014 - 01/2009
1	Deoxyribonuclease I (Nickase)IBA 04/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2024
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	Monounsaturated Fatty AcidsIBA 02/2024
1	palmitoleic acidIBA 02/2024
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2024
1	Oleic Acid (Oleate)IBA 02/2024
1	IronIBA 02/2024
1	6-methyladenineIBA 01/2024
1	Extracellular Matrix ProteinsIBA 01/2024
1	Lipid NanoparticlesIBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2024

Therapy/Procedure

22	Therapeutics 03/2024 - 06/2013
10	Renal Dialysis (Hemodialysis) 04/2023 - 01/2014
8	Drug Therapy (Chemotherapy) 12/2023 - 06/2013
7	Immunotherapy 03/2024 - 01/2020
6	Radiotherapy 03/2024 - 04/2020
4	Radiofrequency Ablation 06/2023 - 01/2018
3	Precision Medicine 11/2023 - 04/2020
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 12/2015
2	Chemoradiotherapy 01/2024 - 08/2022
2	Nephrectomy 04/2023 - 01/2013
2	Intravenous Injections 01/2023 - 01/2019
1	Neurosurgical Procedures 04/2024